Boston Scientific (BSX) Director David Habiger Buys 2,100 Shares

What Happened
David C. Habiger, a director of Boston Scientific Corporation (BSX), reported an open-market purchase of 2,100 shares on August 5, 2026. The filing shows a weighted-average purchase price of $47.59 per share, for a total consideration of $99,937. This was a purchase (insider acquisition), which many investors view as a more informative signal than routine sales.

Key Details

• Transaction type: Open-market purchase (code P).
• Transaction date: 2026-08-05; Form filed: 2026-08-07 (timely filing).
• Price: Weighted average $47.59 per share; prices ranged from $47.21 to $47.98 across multiple trades.
• Shares acquired: 2,100; total value: $99,937.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: The reported $47.59 is a weighted average; the reporting person can provide a breakdown of the number of shares purchased at each separate price upon request by the SEC, issuer, or a security holder.

Context
This was a straightforward open-market purchase by a company director (not an option exercise, gift, or tax-withholding event). Purchases by insiders are often watched by retail investors as a sign of confidence, but they do not by themselves prove future performance.